20 May 2013
Keywords: roche, actemra, beats, mtx, new, ra, studies
Article | 30 June 2008
Swiss drug major Roche's Actemra (tocilizumab) has shown superiority compared against the current standard of care, methotrexate, in new data
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
30 June 2008
17 May 2013
© 2013 thepharmaletter.com